Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Ontrak, Inc.    OTRK

ONTRAK, INC.

(OTRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Glancy Prongay & Murray LLP :, a Leading Securities Fraud Law Firm, Announces Investigation of Ontrak, Inc. (OTRK) on Behalf of Investors

03/03/2021 | 04:04pm EDT

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Ontrak, Inc. (“Ontrak” or the “Company”) (NASDAQ: OTRK) investors concerning the Company’s possible violations of the federal securities laws.

If you suffered a loss on your Ontrak investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at https://www.glancylaw.com/cases/ontrak-inc/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights.

On March 1, 2021, Ontrak issued a press release announced preliminary financial results for fourth quarter and full year 2020. Therein, the Company stated that its largest customer had terminated its contract with Ontrak, effective June 26, 2021. The Company stated that this customer “evaluated Ontrak on a provider basis” and “[a]s such, the customer evaluated [Ontrak’s] performance based on [its] ability to achieve the lowest possible cost per medical visit, and not on [its] clinical outcomes data or medical cost savings.” The Company also stated that “the coaching model which Ontrak has pioneered for over a decade was seen by the customer to be less relevant to their performance metrics.”

On this news, the Company’s share price fell $27.32, or more than 46%, to close at $31.62 per share on March 1, 2021, thereby injuring investors.

Follow us for updates on LinkedIn, Twitter, or Facebook.

Whistleblower Notice: Persons with non-public information regarding Ontrak should consider their options to aid the investigation or take advantage of the SEC Whistleblower Program. Under the program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Charles H. Linehan at 310-201-9150 or 888-773-9224 or email shareholders@glancylaw.com.

About GPM

Glancy Prongay & Murray LLP is a premier law firm representing investors and consumers in securities litigation and other complex class action litigation. ISS Securities Class Action Services has consistently ranked GPM in its annual SCAS Top 50 Report. In 2018, GPM was ranked a top five law firm in number of securities class action settlements, and a top six law firm for total dollar size of settlements. With four offices across the country, GPM’s nearly 40 attorneys have won groundbreaking rulings and recovered billions of dollars for investors and consumers in securities, antitrust, consumer, and employment class actions. GPM’s lawyers have handled cases covering a wide spectrum of corporate misconduct including cases involving financial restatements, internal control weaknesses, earnings management, fraudulent earnings guidance and forward looking statements, auditor misconduct, insider trading, violations of FDA regulations, actions resulting in FDA and DOJ investigations, and many other forms of corporate misconduct. GPM’s attorneys have worked on securities cases relating to nearly all industries and sectors in the financial markets, including, energy, consumer discretionary, consumer staples, real estate and REITs, financial, insurance, information technology, health care, biotech, cryptocurrency, medical devices, and many more. GPM’s past successes have been widely covered by leading news and industry publications such as The Wall Street Journal, The Financial Times, Bloomberg Businessweek, Reuters, the Associated Press, Barron’s, Investor’s Business Daily, Forbes, and Money.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.


© Business Wire 2021
All news about ONTRAK, INC.
04/09ONTRAK, INC. CLASS ACTION REMINDER : Wolf Haldenstein Adler Freeman & Herz LLP r..
PR
04/08ONTRAK, INC.  : Change in Directors or Principal Officers, Financial Statements ..
AQ
04/07HORIZON TECHNOLOGY FINANCE  : Lands Six New Clients During Q1
MT
04/07ONTRAK  : Enters Contract Extension With Health Alliance Medical Plans for Teleh..
MT
04/07ONTRAK  : Extends 6 Year Business Partnership With Health Alliance Medical Plans..
BU
04/06SCOTT+SCOTT ATTORNEYS AT LAW LLP  : Investigates Ontrak, Inc.'s Directors and Of..
BU
04/06SHAREHOLDER ALERT : Pomerantz Law Firm Reminds Shareholders with Losses on their..
PR
04/03ONTRAK  : ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Ontrak, Inc. Investors with..
BU
04/02OTRK LAWSUIT FILING DEADLINE : Bernstein Liebhard LLP Reminds Investors of the D..
PR
04/01ONTRAK  : Signs National Contract with LifeStance Health
BU
More news
Financials (USD)
Sales 2021 97,3 M - -
Net income 2021 -31,2 M - -
Net Debt 2021 - - -
P/E ratio 2021 -19,2x
Yield 2021 -
Capitalization 571 M 571 M -
Capi. / Sales 2021 5,87x
Capi. / Sales 2022 3,66x
Nbr of Employees 724
Free-Float 41,9%
Chart ONTRAK, INC.
Duration : Period :
Ontrak, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ONTRAK, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Average target price 46,00 $
Last Close Price 32,29 $
Spread / Highest target 126%
Spread / Average Target 42,5%
Spread / Lowest Target -0,90%
EPS Revisions
Managers and Directors
NameTitle
Terren S. Peizer Chairman & Chief Executive Officer
Curt Medeiros President & Chief Operating Officer
Brandon H. LaVerne Chief Financial Officer
Jeremiah Stone Chief Technology Officer
Julia Wright Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
ONTRAK, INC.-47.74%571
CVS HEALTH CORPORATION8.45%97 144
HCA HEALTHCARE, INC.16.06%64 315
LABORATORY CORPORATION OF AMERICA HOLDINGS25.15%24 874
REDE D'OR SÃO LUIZ S.A.-3.07%22 661
FRESENIUS MEDICAL CARE AG & CO. KGAA-6.98%22 080